Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Clinical trial NCT06398158 · RECRUITING
Trial details
- NCT number
- NCT06398158
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-10
- Primary completion
- 2026-12-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.